Prometheus Biosciences, Inc. Common Stock (RXDX)

RXDX was delisted on the 15th of June, 2023.

• Market cap: $9.56B
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Prometheus Biosciences Inc is a biotechnology company pioneering a precision medicine approach to the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment and diagnosis of IBD.

Employees: 97